Ozalin (Midazolam)

Midazolam, the active ingredient in Ozalin, is a benzodiazepine presented as a strength/form for parenteral use. It is employed for sedation, anxiolysis, and seizure control in hospital settings. GNH USA supplies Ozalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ozalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Midazolam is a short‑acting benzodiazepine that acts on the central nervous system to produce sedation and anxiolysis.

- Pre‑operative sedation: facilitates calmness and amnesia before surgery. - Procedural sedation: provides rapid onset sedation for diagnostic or minor therapeutic procedures. - Status epilepticus: helps terminate ongoing seizures when rapid control is needed. - Intensive care unit sedation: maintains a controllable level of sedation for mechanically ventilated patients. - Anxiolysis in acute settings: reduces severe anxiety episodes in emergency or peri‑procedural contexts.

Midazolam may exhibit several adverse reactions that vary in frequency and severity.

Common Side Effects: - Drowsiness - Dizziness - Headache - Nausea - Mild respiratory depression - Hypotension

Serious or Rare Side Effects: - Severe respiratory depression - Paradoxical agitation or aggression - Cardiac arrhythmias - Anaphylaxis - Persistent amnesia - Withdrawal seizures

When using Midazolam, several precautions should be considered to ensure safe administration.

- Patient assessment: evaluate   - Monitoring:   - Contra‑   - Drug‑   - Store  

Midazole  

---